Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
paracetamol, caffeine, phenylephrine (phenylephrine hydrochloride), terpin hydrate, ascorbic acid
S.C. Europharm S.A.
paracetamol, caffeine, phenylephrine (phenylephrine hydrochloride), terpin hydrate, ascorbic acid
500mg+25mg+5mg+20mg+30mg
tablets
OTC
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Coldrex Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Paracetamol Ph.Eur. 500.0mg, Caffeine Ph.Eur. 25.0mg, Phenylephrine hydrochloride Ph Eur 5 mg, Terpin Hydrate BPC 20 mg, Ascorbic Acid 30 mg. 3. PHARMACEUTICAL FORM Tablet. 4. CLINICAL PARTICULARS THERAPEUTIC INDICATIONS For the relief of symptoms of colds and influenza such as increased body temperature, headache, fever, muscle and joint pain, nose blocking, pain in nasal sinus and sore throat. POSOLOGY AND METHOD OF ADMINISTRATION Adults and children older than 12 years: 1-2 tablets taken every 4-6 hours, if required. Intervals between administrations – not less than 4 hours. Do not exceed 8 tablets in 24 hours. Children: Not recommended for children under 12 years. Method of administration Coldrex Tablets are for oral administration only. This product is not recommended to be used during more than five days as an analgesic and three days as an antipyretic without a consultation with doctor. Increasing of daily dose or prolongation of a treatment is possible only under medical supervision. Consult a doctor if symptoms persist. Do not exceed the stated dose. In case of overdosing immediately seek for medical help, even if you feel well. CONTRAINDICATIONS Medicine should not be administered concurrently with other paracetamol-containing products, decongestions or product for treatment of cold and flu, tricyclic antidepressants, beta-blockers or other anti-hypertonic drugs, inhibitors of MAO (including the period of 14 days after stopping of administration), sympathomimetics (such as appetite suppressors, amphetamine-like psycostimulators), it should not be taken in patients hypersensitive to ingredients that constitute this medicine, patients with hereditary absence of glucose-6-phosphate dehydrogenase, diseases of blood system, severe liver or kidney dysfunction, cardio-vascular diseases (ischemic heart disease, infarct of myocardium, aortic stenosis, evident athe Read the complete document